Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2020-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523997/?tool=EBI

Similar Items

Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.
by: PLOS ONE Staff
Published: (2020-01-01)

Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level.
by: Ronald B Moss, et al.
Published: (2020-01-01)

Higher doses of naloxone are needed in the synthetic opioid era
by: Ronald B. Moss, et al.
Published: (2019-02-01)

The Effects of Intramuscular Naloxone Dose on Mu Receptor Displacement of Carfentanil in Rhesus Monkeys
by: Peter J. H. Scott, et al.
Published: (2020-03-01)

High-affinity naloxone binding to filamin a prevents mu opioid receptor-Gs coupling underlying opioid tolerance and dependence.
by: Hoau-Yan Wang, et al.
Published: (2008-01-01)

Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene
by: Tao Pao-Luh, et al.
Published: (2010-04-01)

Non-injectable naloxone for the prevention of opioid overdose deaths
by: McDonald, Rebecca Silvia
Published: (2018)

Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine.
by: Hoau-Yan Wang, et al.
Published: (2009-01-01)

Ultra-low-dose naloxone added to fentanyl and lidocaine for peribulbar anesthesia: A randomized controlled trial
by: Hoda Alsaid Ahmed Ezz, et al.
Published: (2015-04-01)

Naloxone interventions in opioid overdoses: a systematic review protocol
by: Lindsay Victoria Shaw, et al.
Published: (2019-06-01)

Naloxone should remain the appropriate antidote to treat opioid overdose
by: Bruno Mégarbane, et al.
Published: (2020-04-01)

Opioid Education and Nasal Naloxone Rescue Kits in the Emergency Department
by: Dwyer, Kristin, et al.
Published: (2015-05-01)

Effect of forced treadmill exercise and blocking of opioid receptors with naloxone on memory in male rats
by: Atefeh Asadi Rizi, et al.
Published: (2016-01-01)

Preventing deaths from rising opioid overdose in the US – the promise of naloxone antidote in community-based naloxone take-home programs
by: Straus MM, et al.
Published: (2013-09-01)

Comparative pharmacoeconomic analysis of oxycodone/naloxone combination analgesic and fentanyl transdermal delivery system
by: A. E. Cheberda, et al.
Published: (2018-05-01)

Analysis of increased public access to naloxone as a method to control the recent fentanyl epidemic
by: Pellegrini, Eric
Published: (2016)

Point-of-sale Naloxone: Novel Community-based Research to Identify Naloxone Availability
by: Travis Olives, et al.
Published: (2020-08-01)

Naloxone urban legends and the opioid crisis: what is the role of public health?
by: Alexis Crabtree, et al.
Published: (2019-05-01)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
by: Mauger S, et al.
Published: (2014-04-01)

Microneedle-mediated transdermal delivery of naloxone hydrochloride for treatment of opioid addiction
by: Frempong, Dorcas, et al.
Published: (2021)

“They’re not doing enough.”: women’s experiences with opioids and naloxone in Toronto
by: Emilie R. Macleod, et al.
Published: (2021-03-01)

Effect of Low-Dose Naloxone on Pain Severity and Side Effects of Opioids on Patients Undergoing Laparoscopic Cholecystectomy
by: Karamollah Toolabi, et al.
Published: (2018-04-01)

Naloxone induced pulmonary edema
by: Sherif Elkattawy, et al.
Published: (2021-01-01)

Community Pharmacist Engagement in Co-Dispensing Naloxone to Patients at Risk for Opioid Overdose
by: Salwan, A., et al.
Published: (2019)

Rural Jail Administrators Perceptions of Take-Home Naloxone to Control Opioid Overdoses
by: Woollett, Jaclyn
Published: (2017)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
by: Soyka M
Published: (2015-01-01)

Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose
by: Merlin MA, et al.
Published: (2015-06-01)

Practical implications of naloxone knowledge among suburban people who use opioids
by: Kristin E. Schneider, et al.
Published: (2021-04-01)

Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
by: Webster LR, et al.
Published: (2015-11-01)

Naloxone analgesia in BALBc mice : a dose-dependent relationship
by: Vaccarino, Anthony Leonard.
Published: (1987)

Current status and views of Methadone and Buprenorphine/Naloxone Maintenance Treatment in Patients with Opioid-Addiction
by: YA-LI LIANG, et al.
Published: (2018)

Preventing opioid overdose with peer-administered naloxone: findings from a rural state
by: Bridget L. Hanson, et al.
Published: (2020-01-01)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
by: Yvette N. Martin, et al.
Published: (2019-05-01)

Geospatial Clustering of Opioid-Related Emergency Medical Services Runs for Public Deployment of Naloxone
by: Daniel A. Dworkis, et al.
Published: (2018-06-01)

Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review
by: Lewis CR, et al.
Published: (2017-10-01)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Desai, P.H, et al.
Published: (2021)

Naloxone formulation for overdose reversal preference among patients receiving opioids for pain management
by: Barrett, F.S, et al.
Published: (2018)

Naloxone precipitated withdrawal increases dopamine release in the dorsal striatum of opioid dependent men
by: Ehsan Shokri-Kojori, et al.
Published: (2021-09-01)

Effect of Combining Ultralow-dose Naloxone with Morphine in Intravenous Patient-controlled Analgesia: The Cut-off Ratio of Naloxone to Morphine for Antiemesis After Gynecologic Surgery
by: Yu-Chang Yeh, et al.
Published: (2008-06-01)

Correction to: Comparative Human Factors Evaluation of Two Nasal Naloxone Administration Devices: NARCAN® Nasal Spray and Naloxone Prefilled Syringe with Nasal Atomizer
by: Kathryn G. Tippey, et al.
Published: (2019-05-01)